Posts about tb

Using Rats to Sniff Out TB

Apopo’s African giant pouched rats are being used to sniff out mines and TB

In the face of what the World Health Organisation is calling a global TB epidemic, an innovative tech startup named Apopo is attempting to reverse the harrowing statistics, using rodents to sniff out TB in cough and spit samples.

No ordinary lab rats, Apopo’s African giant pouched rats – affectionately named HeroRats – are extremely sensitive to smell, with more genetic material allocated to olfaction than any other mammal species. They are also highly social animals, and can be trained to communicate with humans.

I have written about these wonderful rats previously, Appropriate Technology: Rats Helping Humans by Sniffing Out Land Mines. As I have stated many time I especially enjoy engineering solutions that use affordable and effective methods to help everyone.

Photo of Hero-rat detecting TB in Mozambique with Apopo staff person

Hero-rat detecting TB in Mozambique

A DNA-screening device that takes up to two hours to analyse each individual sample with 95pc accuracy costs $17,000 and thousands more in upkeep. By contrast, a HeroRat costs $6,500 to train, can probe through hundreds of samples every hour [70-85% accuracy rate], and requires only food, water and cages for shelter.

Keep these innovations coming. The USA needs them also given the massively costly healthcare system in the USA.

The TB sniffing rat program was developed through Apopo in Tanzania.

Related: Rats Show Empathy-driven BehaviorBeehive Fence Protects Farms from ElephantsTuberculosis Risk (2007)Dangerous Drug-Resistant Strains of TB are a Growing Threat (2012)

Teixobactin – New Antibiotic Attacks Ability of Bacteria to Build Cell Walls

New class of antibiotic could turn the tables in battle against superbugs

The antibiotic, called teixobactin, kills a wide range of drug-resistant bacteria, including MRSA and bugs that cause TB and a host of other life-threatening infections.

It could become a powerful weapon in the battle against antimicrobial resistance, because it kills microbes by blocking their capacity to build their cell walls, making it extremely difficult for bacteria to evolve resistance.

It would be great if the exciting results carried through to real world results similar to the hope. Medical research is full of promising initial results that fail to deliver, however. We are at great risk if some new miracle anti-biotic isn’t found. Many people are investigating potential solutions.

Most antibiotics are isolated from bacteria or fungi that churn out lethal compounds to keep other microbes at bay. But scientists have checked only a tiny fraction of bugs for their ability to produce potential antibiotics because 99% cannot be grown in laboratories.

Lewis’s group found a way around the problem by developing a device called an iChip that cultures bacteria in their natural habitat. The device sandwiches the bugs between two permeable sheets. It is then pushed back into the ground where the microbes grow into colonies.

Working with a Massachusetts-based company, NovoBiotic, and researchers at the University of Bonn, [Kim] Lewis’s group screened 10,000 soil bacteria for antibiotics and discovered 25 new compounds. Of these, teixobactin was the most promising.

Though promising, Lewis said that years more work lie ahead before the drug could be available. Human clinical trials could begin within two years to check its safety and efficacy, but more development would follow that.

It is wonderful to read about the great work so many scientists are making in researching potential life saving drugs. Hopefully this antibiotic will save us from what will be catastrophic harm if some new antibiotic is not available soon.

Related: Search for Antibiotic Solutions Continues: Killing Sleeper Bacteria Cells (2013)New Family of Antibacterial Agents Discovered (2009)Potential Antibiotic Alternative to Treat Infection Without Resistance (2012)

Dangerous Drug-Resistant Strains of TB are a Growing Threat

Drug-resistant strains of TB are out of control

The fight against new, antibiotic-resistant strains of tuberculosis has already been lost in some parts of the world, according to a senior World Health Organisation expert.

Dr Paul Nunn, head of the WHO’s global TB response team, is leading the efforts against multi-drug resistant TB (MDR-TB). Nunn said that, while TB is preventable and curable, a combination of bad management and misdiagnosis was leaving pharmaceutical companies struggling to keep up. Meanwhile, the disease kills millions every year.

“It occurs basically when the health system screws up,” said Nunn. “Treating TB requires a carefully followed regime of medication over six months. In places where health services are fragmented or underfunded, or patients poor and health professionals ill-trained, that treatment can fall short, which can in turn lead to patients developing drug-resistant strains. It’s been estimated that an undiagnosed TB-infected person can infect 10 others a year.

We tend to do a poor job of dealing with systemic effects of poorly functioning systems. Direct present threats get out attention. And we are decent at directing brain power and resources to find solutions. We are not very good at dealing with failures that put us in much worse shape in the long term. For small threats we can wait until it becomes a present threat and then deal with it. There are costs to doing this (economic and personal) but it can be done.

Some problems though become enormously complicated to deal with once they become obvious. Global climate change, for example. And often, even once they are obvious, we won’t act until the costs (economic and in human lives) are very large. It is possible that once we decide to get serious about dealing with some of these issues that the costs (economic and in human lives) will be catastrophic.

The failure to use anti-biotics medicine properly is a very serious threat to become one of these catastrophic societal failures. While tuberculosis failures may be larger in poorer countries, rich countries are failing probably much more critically in the misuse of anti-biotics (I would guess, without having much evidence at my fingertips to back up my opinion. I believe the evidence exists I am just not an expert). These failures have huge costs for all of humanity but we are risking many premature deaths because we systemically fail to deal with issues until the consequences are immediate.

Related: Extensively Drug-resistant Tuberculosis (XDR TB) (2007)What Happens If the Overuse of Antibiotics Leads to Them No Longer Working?Antibiotics Too Often Prescribed for Sinus WoesOveruse of Antibiotics (post from 2005)CDC Urges Increased Effort to Reduce Drug-Resistant Infections (2006)

Searching for More Effective Tuberculosis Drugs

In India: A Search for More Effective Tuberculosis Drugs

The multi-drug regimen is a major problem for several reasons. It requires TB patients to manage taking four drugs exactly as prescribed over six to nine months. If patients don’t take the full course of the medicines, the TB bacteria may develop resistance to the drugs and become even more difficult to treat. To reduce that risk, many countries require that patients go to a clinic so a healthcare professional can watch them take the medication and ensure they are complying with their drug-treatment regimen. This is both expensive and time consuming. Gokhale said that a single drug that targets multiple pathways could save time and money by eliminating the need to take so many drugs over such a long period of time.

To create their new compound, Gokhale and his colleagues exploited an evolutionary quirk in the way Mycobacterium tuberculosis builds the lipid layer that coats its surface. Unlike other organisms, M. tuberculosis displays a suite of complex lipids on its outer membrane. Some scientists have suggested that these long lipid molecules contribute to the bacteria’s ability to maintain long-term infections by confusing the host’s immune system.

Related: Fighting TuberculosisTB Pandemic ThreatExtensively Drug-resistant Tuberculosis (XDR TB)Virtually untreatable TB found

TB Pandemic Threat

The dilemma of a deadly disease: patients may be forcibly detained

More than 300 cases of the highly infectious disease, which is spread by airborne droplets and kills 98% of those infected within about two weeks, have been identified in South Africa.

But doctors believe there have been hundreds, possibly thousands, more and the numbers are growing among the millions of people with HIV, who are particularly vulnerable to the disease. Their fear is that patients with XDR-TB, told that there is little that can be done for them, will leave the isolation wards and go home to die. But while they are still walking around they risk spreading the infection.

Related: ‘Virtually untreatable’ TB foundPrevention and Treatment of Tuberculosis in the Coming CenturyUN Special Envoy warns of deadly synergy between TB and HIV

‘Virtually untreatable’ TB found

‘Virtually untreatable’ TB found:

TB presently causes about 1.7 million deaths a year worldwide, but researchers are worried about the emergence of strains that are resistant to drugs.

Drug resistance is caused by poor TB control, through taking the wrong types of drugs for the incorrect duration.

Multi-drug resistant TB (MDR TB), which describes strains of TB that are resistant to at least two of the main first-line TB drugs, is already a growing concern.

Globally, the WHO estimates there are about 425,000 cases of MDR TB a year, mostly occurring in the former Soviet Union, China and India.

TB Related posts: Extensively Drug-resistant Tuberculosis (XDR TB), May 2007Deadly TB Strain is Spreading, WHO Warns, Mar 2007Tuberculosis Pandemic Threat, Jan 2007

Related: Evolution of Antibiotic ResistanceOveruse of Antibiotics